Matches 1 - 50 out of 358 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20110240512 Antibiotic Formulations Providing Reduced Gastrointestinal Side Effects and Clostridium difficile Infection Relapse, and Related Methods  
The invention includes a formulation comprising: (i) a therapeutically effective amount of at least one antibiotic; and (ii) a therapeutically effective amount of at least one probiotic material....
US20120128632 IDENTITY MARKERS  
Methods for identifying trichogenic dermal cells, including dermal papilla cells and dermal sheath cells, capable of inducing hair follicle formation when injected into skin are provided. It has...
US20120034190 YEAST STRAINS AND THEIR USES IN THE PRODUCTION OF LIPIDS  
The invention is directed to isolated microorganisms, as well as biomasses, cultures, microbial oils, and compositions thereof. The invention also provides methods of producing the microbial oils...
US20120183505 ARTIFICIAL DERMIS AND METHOD OF PREPARATION  
Artificial dermis (1) obtained from plasma with platelets (2) and human fibroblasts. The plasma with platelets (2) is obtained from the fractionating of total blood (4) from the patient (8) by...
US20150079040 PROBIOTIC BACTERIA  
The invention provides probiotic bacteria and lysates thereof for use in methods of medical and cosmetic treatment. Use in the treatment of infections, including skin infections and methods...
US20130202561 METHOD OF TREATING DRAINS USING FUNGUS CULTURES  
A method of treating drain systems containing organic matter and providing a biopesticide for killing insects is provided. The method comprises introducing into a drain system a bacterial culture,...
US20120276054 Alternative bacterial treatment  
Alternative treatments are provided for use in the inhibition, decrease, therapeutic or prophylactic support of a Bdellovibrio and like organism (BALO) Gram negative prey bacterial infection in a...
US20120244125 BIFIDOBACTERIUM LONGUM ATCC BAA-999 (BL999) AND WEIGHT CONTROL  
The present invention generally relates to the field of weight management. The present invention relates for example to the use of Bifidobacterium longum ATCC BAA-999 to support weight management,...
US20140079669 FORMULATION AND METHOD FOR TREATING PLANTS TO CONTROL OR SUPPRESS A PLANT PATHOGEN  
The present invention provides formulations and methods for preventing, suppressing, treating, or controlling pre- or post-harvest disease or decay in plants. In the inventive method, plants are...
US20110293569 LACTOBACILLUS RHAMNOSUS CNCM I-4096 AND WEIGHT CONTROL  
The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity....
US20110293568 LACTOBACILLUS HELVETICUS CNCM I-4095 AND WEIGHT CONTROL  
The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to support weight management and to treat or prevent obesity....
US20120308523 Method for Reducing Gastro-Intestinal Inflammation Using Bifidobacterium Animalis Bacteria or a Fermented Dairy Product Comprising Such Bacteria  
The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in...
US20120003317 STABLE PROBIOTIC GRANULATE, AND METHOD FOR PREPARING SAME  
The invention pertains to the field of probiotic compositions useful for human and/or animal food and health. The invention particularly relates to compositions containing stable probiotic...
US20140234259 Natural Intra-Vaginal Inserts to Control Imbalanced pH  
A vaginal insert controls pH within a human vagina by use of various probiotics which include lactobacillus reuteri, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum,...
US20150118190 LACTOBACILLUS RHAMNOSUS AND BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS FOR USE IN PREVENTION OR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS  
The present invention relates to a composition comprising Lactobacillus rhamnosus, preferably strain ATCC53103, and Bifidobacterium animalis subsp. lactis, preferably strain DSM 15954, for use in...
US20150079039 SINUSITIS DIAGNOSTICS AND TREATMENTS  
Provided herein are compositions for improving sinus microbiota and treating sinusits. Further provided are methods of detecting imbalance in the sinus microbiota that can be indicative of...
US20120039852 LACTOBACILLUS RHAMNOSUS NCC4007, A PROBIOTIC MIXTURE AND WEIGHT CONTROL  
The present invention generally relates to the field of weight management and obesity. In particular the present invention relates to the use of probiotics in combination with prebiotics to treat...
US20130022575 SYSTEMS AND METHODS OF REPLACING INTESTINAL FLORA  
The invention relates to one or more systems and methods for creating a mixture of cultures used to replace intestinal flora. Specifically, the invention relates to methods and systems of treating...
US20130136796 Acellular Bioabsorbable Tissue Regeneration Matrices  
The present invention provides methods and compositions useful in the regeneration of damaged, lost and/or degenerated tissue in humans and animals. In certain embodiments, the present invention...
US20150050245 METHODS AND DELIVERY SYSTEM FOR BENEFICIAL ADDITIVE AND SUBTRACTIVE BIOLOGICAL AGENTS TO PROMOTE BALANCED MAMMALIAN GASTROINTESTINAL FLORA  
This invention relates to controlled release formulations of probiotic bacteria and bacteriophages, including combined formulations of probiotic bacteria and bacteriophages. The formulations...
US20120014921 TREATMENT OF STROKE AND OTHER ACUTE NEURAL DEGENERATIVE DISORDERS VIA INTRANASAL ADMINISTRATION OF UMBILICAL CORD-DERIVED CELLS  
This invention relates to methods of treating stroke by intranasal administration of umbilical cord tissue-derived cells, which are isolated from mammalian umbilical cord tissue substantially free...
US20140363397 METHOD FOR TREATMENT OF DISORDERS OF THE GASTROINTESTINAL SYSTEM  
There are provided novel synthetic stool preparations comprising bacteria isolated from a fecal sample from a healthy donor. The synthetic stool preparations are used for treating disorders of the...
US20140120152 Scaffold Delivery of Immune Suppressors and Transplant Material for Control of Transplant Rejection  
The present invention provides compositions, devices, and methods for the coordinated delivery of transplant material and immune suppressors for control of transplant rejection. In particular...
US20140205572 COMPOSITION AND METHOD FOR INCREASING EFFECTIVENESS OF RADIATION OR CHEMOTHERAPY  
This invention is a composition containing prebiotics, Lentinula edodes mycelia extract, and Litchi chinensis fruit polyphenol and use of the same in increasing the effectiveness of radiation or...
US20110268702 LACTOBACILLUS PARACASEI AND WEIGHT CONTROL  
The present invention generally relates to the field of obesity and/or metabolic disorders. In particular the present invention relates to the use of probiotics to treat obesity and/or metabolic...
US20150174178 Method and System for Prevention and Treatment of Allergic and Inflammatory Diseases  
A method and system for exposing an expectant mother to a mixture of farm derived manure-containing soil to reduce the chances her baby will suffer allergies. City dwelling expectant mothers are...
US20110256207 WHOLE GRAIN FLOUR AND PRODUCTS INCLUDING SAME  
The present invention is a grain product. The grain product includes a first fraction including bran. The first fraction is milled to a first particle size of less than 500 micrometers. The grain...
US20110200561 Method for Bacteriophage Delivery and Amplification  
Disclosed are methods of selecting wide host range bacteriophage capable of growing in a plurality of bacteria including pathogenic and non-pathogenic bacteria and bacteriophage selected by the...
US20150150919 COMPOSITIONS COMPRISING COCKTAILS OF ANTIBACTERIAL PHAGES AND USES THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS  
The present invention is directed to the field of phage therapy for the treatment and control of bacterial infections, in particular diabetic foot infections. More specifically, the present...
US20140086875 COMPOSITION BASED ON BACILLUS SPP. AND CORRELATE GENERA AND THEIR USE IN PEST CONTROL  
The objective of the current invention is the control of agricultural infestations based on alternative methods that are less aggressive to the environment and that are harmless to other...
US20140348795 NUTRITIONAL BEVERAGE POWDER AND METHOD OF MAKING SAME  
A nutraceutical compound designed to promote cellular health, cleanse and replenish a body's gastro-intestinal tract and system, balance a body's natural defense system, keep the immune system...
US20130202562 LIQUID MICROORGANISM CONSORTIA FORMULATION  
The present invention is directed to compositions and methods using microorganisms to benefit an environment or recipient subject. The present invention relates to the use of microorganism based...
US20120315249 Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes  
The invention provides a method and composition for ameliorating or reducing the symptoms, signs, and markers and for the treatment of irritable bowel syndrome, inflammatory bowel disease or...
US20130095073 SKIN PROPERTIES IMPROVING AGENT FOR ORAL ADMINISTRATION  
Disclosed is a skin property-improving agent which exerts excellent effects by oral administration. The skin property-improving agent for oral administration contains, as an active ingredient, a...
US20150259647 HUMAN ADIPOSE TISSUE WHITE AND 'BROWN-ON-WHITE' PROGENITORS FOR RECONSTRUCTIVE AND METABOLIC THERAPIES  
Methods for preparation of prospectively identified human adipose stem cells enriched populations thereof, e.g., for therapy.
US20130089524 L. JOHNSONII LA1, B. LONGUM NCC2705 AND IMMUNE DISORDERS  
The present invention generally relates to the field of probiotics, and in particular to preventing and/or treating inflammatory and infectious disorders, for example by boosting the endogenous...
US20140050766 TISSUE ENGINEERING CONSTRUCT COMPRISING FIBRIN  
A three-dimensional fibrin engineered tissue construct is provided selected from: (i) a fibrin gel matrix comprising a combination of tissue-specific cells and at least one type of vascular cells;...
US20110300108 Herbal Compositions for the Control of Hematophagous Parasites  
There is described an herbal hematophagous parasite control composition which comprises Picraena excelsa (Quassia), Foeniculum vulgare (fennel) and Azadirachta indica folium (Neem) provided that...
US20120100108 COMPOSITIONS AND METHODS OF TREATING NO-OPTION CRITICAL LIMB ISCHEMIA (CLI)  
The present invention provides methods for treating critical limb ischemia (CLI), including increasing wound healing, decreasing wound size, increasing survival-free amputation, preventing...
US20120134963 COMPOSITIONS AND METHODS FOR ENHANCING VIRUS EFFICACY  
Provided are viral sensitizing compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of...
US20130045185 STRAINS AND METHODS USEFUL FOR MYCOTOXINS  
The disclosure relates to strains, compositions and methods for detoxifying a mycotoxin. In another embodiment, the disclosure relates to strains, compositions and methods for alleviating the...
US20130022576 COMPOSITIONS AND METHODS FOR REDUCING THE INCIDENCE OF EQUINE DIGESTIVE DISORDERS  
The present invention encompasses compositions and methods of reducing the incidence of equine digestive disorders.
US20140364309 Active Compounds Combination Containing Fluopyram Bacillus and Biologically Control Agent  
The present invention relates to active compound combinations and compostions for reducing the damage of plants and plant parts as well as losses in harvested fruits or vegetables caused by...
US20140356329 PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS  
The present invention provides probiotic compositions suitable for reducing the incidence and duration of human illness. In particular, the present invention provides methods and compositions...
US20140023620 PROBIOTIC COMPOSITION  
Disclosed herein are probiotic compositions comprising a mixture of at least two probiotic bacteria, including Streptococcus salivarius K12® (BLIS K12®) and at least a Lactobacillus bacteria. The...
US20110182860 BIOCONTROL COMPOSITE MICROBIAL AGENT PSX COMBINATION FOR CONTROLLING SEVERAL SOIL-BORNE DISEASES AND ITS BACTERIOLOGICAL COMPOSITION  
A composite biocontrol microbial agent PSX combination controls several soil-borne diseases. The PSX combination was composed of three biocontrol bacteria, which are shaking cultured in the PDA...
US20110280838 TREATMENT OF INTERVERTEBRAL DISC DEGENERATION USING HUMAN UMBILICAL CORD TISSUE-DERIVED CELLS  
Methods for treating a patient having a disease or condition related to IVD degeneration are provided. The methods comprise administering cells obtained from human umbilical cord tissue, or...
US20150202238 COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE  
Methods and compositions for treating inflammatory bowel disease involve the use of targeted antibiotics in combination with probiotic formulations. The probiotics mitigate many of the deleterious...
US20120276201 COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE  
Methods and compositions for treating inflammatory bowel disease involve the use of targeted antibiotics in combination with probiotic formulations. The probiotics mitigate many of the deleterious...
US20120114609 BIOLOGICAL MATERIAL SUITABLE FOR THE THERAPY OF OSTEOARTHROSIS, LIGAMENT DAMAGE AND FOR THE TREATMENT OF JOINT DISORDERS  
The present invention regards a biological material comprising: a) a liquid carrier comprising a viscous solution containing at least one natural and/or semisynthetic polysaccharide, and having a...

Matches 1 - 50 out of 358 1 2 3 4 5 6 7 8 >